本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Lyra Therapeutics

0.1047
+0.00565.65%
成交量:54.00万
成交额:5.56万
市值:689.77万
市盈率:-0.07
高:0.1055
开:0.0991
低:0.0991
收:0.0991
数据加载中...
2023/09/13

重要事件披露

Form 8-K - Current report
2023/09/01

重要事件披露

Form 8-K - Current report
2023/08/26

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/08/08

重要事件披露

Form 8-K - Current report
2023/08/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/07/15

重要事件披露

Form 8-K - Current report
2023/07/06

SEC问询函

Form CORRESP - Correspondence
2023/06/16

重要事件披露

Form 8-K - Current report
2023/06/13

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/06/09

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/06/02

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/06/01

重要事件披露

Form 8-K - Current report
2023/05/12

重要事件披露

8-K - Current report
2023/05/12

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/03/29

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/03/29

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2023/03/29

重要事件披露

8-K - Current report
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/13

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals